The pharmacology of salmeterol
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 52 (26) , 2131-2143
- https://doi.org/10.1016/0024-3205(93)90728-l
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The therapeutic potential of long‐acting β2‐adrenoceptor agonists in allergic inflammationClinical and Experimental Allergy, 1992
- Salmeterol: a potent and long‐acting inhibitor of inflammatory mediator release from human lungBritish Journal of Pharmacology, 1991
- Salmeterol, a novel, long‐acting β2‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivoBritish Journal of Pharmacology, 1991
- The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta‐ adrenoceptor agonists.British Journal of Clinical Pharmacology, 1991
- Biophysical and genetic analysis of the ligand-binding site of the β-adrenoceptorTrends in Pharmacological Sciences, 1991
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: Propranolol, nimodipine and amiodarone+Journal of Molecular and Cellular Cardiology, 1988
- Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine*1Journal of Allergy and Clinical Immunology, 1987
- THE ROLE OF β‐KECEPTOR AGONISTS IN THE INHIBITION OF PULMONARY EDEMAAnnals of the New York Academy of Sciences, 1982